Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace

Go back to Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace
CHARLES RIVER LABORATORIE (NYSE: CRL) Delayed: 295.19 +3.74 (1.28%)
Previous Close $291.45    52 Week High $89.18 
Open $291.78    52 Week Low $65.70 
Day High $298.18    P/E 137.30 
Day Low $289.07    EPS $2.15 
Volume 887,562       

Danaher Corp. (NYSE: DHR) Delayed: 218.85 +2.94 (1.36%)
Previous Close $215.91    52 Week High $102.79 
Open $215.58    52 Week Low $75.71 
Day High $220.25    P/E 57.59 
Day Low $213.46    EPS $3.80 
Volume 4,701,824       

ICON (NASDAQ: ICLR) Delayed: 172.23 -2.03 (1.16%)
Previous Close $174.26    52 Week High $85.74 
Open $173.02    52 Week Low $62.31 
Day High $179.02    P/E N/A 
Day Low $172.03    EPS $0.00 
Volume 391,180       

Medspas of America, Inc. New (NASDAQ: MEDP) Delayed: 620.75 +8.11 (1.32%)
Previous Close $612.64    52 Week High $35.58 
Open $614.13    52 Week Low $26.54 
Day High $629.69    P/E N/A 
Day Low $600.01    EPS $0.00 
Volume 225,883       

Thermo Fisher Scientific (NYSE: TMO) Delayed: 629.27 +1.72 (0.27%)
Previous Close $627.55    52 Week High $160.68 
Open $626.48    52 Week Low $119.75 
Day High $629.51    P/E 179.79 
Day Low $616.27    EPS $3.50 
Volume 1,556,078